Skip to main content


Key facts

Cohort: Cohort 6, 2021 

Focus in insurance value chain/workflow: Point of underwriting 

Specific lines of business supported: Personal  

Founded: 2019

Status: Operating, still in insurance

Company type: MGA

Head office: United Kingdom

Main global offices: United Kingdom

Locations served: United Kingdom, USA

Employee count: 11-100


Gaia has created an IVF (in vitro fertilisation) insurance product that predicts fertility outcomes and insures against the risk of failure. The product is an embedded insurance, financing, and payment solution integrated into UK fertility clinics with customers paying off the treatment when they have a child. Patients build and choose insurance coverage at the point of sale, online. The company also offers members access to qualified medical and counselling support. 

Lab activity

Primary focus product area whilst in the Accelerator: Fertility

Gaia developed its IVF insurance product whilst in the Accelerator. During the Lab, Gaia updated its existing model, which could then be used to predict the change of success during IVF, to also suggest how many cycles may be needed to achieve pregnancy. Gaia met its current capacity providers, Chaucer and Beazley, through the Lab and continues to work closely with them.  

“The Accelerator helped us in two ways. It gave us access to a large group of people in a structured format to test our product. It also allowed us to work in a cohort with people that were serious about considering alternative products, distribution channels and capacity.”
Nader AlSalim, Founder and Chief Executive Officer

Explore all our alumni

Learn about all our alumni who have take part in the Lloyd’s Lab Accelerator programme.